Peter B. Rahl

Whitehead Institute for Biomedical Research

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc”.

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Cell(2011)10.1016/j.cell.2011.08.017

N/A

1.2DataRank · unranked

2871 citations

Ghayas C. Issa, Madeleine E. Lemieux, Peter B. Rahl, Junwei Shi, Hannah M. Jacobs +19 more

Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms

Immunity(2014)10.1016/j.immuni.2014.04.004

N/A

0.844DataRank · unranked

276 citations

Nir Yosef, Jianfei Yang, Yonghui Wang, Ling Zhou, Chen Zhu +23 more

Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

Cancer Research(2025)10.1158/0008-5472.can-25-3440

N/A

0DataRank · unranked

2 citations

Michael R. McKeown, Giulia Giorgetti, Marek J. Kobylarz, Tamara D. Hopkins, Wayne L. Glore +18 more